Investigation of urinary levels of salbutamol in asthmatic patients receiving inhaled therapy

Journal of Clinical Pharmacy and Therapeutics

Volumn 22, Issue 2, 1997, Pages 119-126

  Jacobson, G A ^a   Peterson, G M ^a   McLean, S ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; SALBUTAMOL;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DETERMINATION; DRUG MONITORING; DRUG URINE LEVEL; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INHALER; MAJOR CLINICAL STUDY; MALE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION;

EID: 0030824724     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2710.1997.tb00005.x     Document Type: Article

References (29)

1. National Heart, Lung and Blood Institute. (1992) International Consensus Report on Diagnosis and Management of Asthma. National Heart, Lung and Blood Institute Publication NIH 92-3091. U.S. Department of Health and Human Services, Bethesda, MD.
2. Woolcock A, Rubinfeld AR, Seale JP, et al. (1989) Asthma management plan, 1989. Medical Journal of Australia, 151, 650-653.
3. National Health and Medical Research Council Working Party on Asthma Associated Deaths. (1988) Asthma in Australia. Strategies for Reducing Morbidity and Mortality. National Health and Medical Research Council, Canberra.
4. Editorial. (1993) Towards an international consensus on asthma management. Drugs and Therapy Perspectives, 1, 7-10.
5. Tse M, Bridges-Webb C. (1993) Asthma management in general practice. Medical Journal of Australia, 158, 766-770.
6. Sears MR, Taylor RB, Print CG, et al. (1990) Regular inhaled beta-agonist treatment in bronchial asthma. Lancet, 336, 1391-1396.
7. van Schayck CP, Dompeling E, van Herwaarden CLA, et al. (1991) Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study. British Medical Journal, 303, 1426-1431.
8. Taylor DR, Hensley MJ. (1993) Regular inhaled beta agonist drug therapy: is it appropriate treatment for asthma? Australian Prescriber, 16, 2-4.
9. 2adrenergic agonists. Effects on airway function in patients with asthma. Archives of Internal Medicine, 156, 1514-1520.
10. Ernst P, Spitzer WO, Suissa S, et al. (1992) Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. Journal of the American Medical Association, 268, 3462-3464.
11. Robin ED, McCauley R. (1992) Sudden cardiac death in bronchial asthma, and inhaled beta-adrenergic agonists. Chest, 101, 1699-1702.
12. Taburet AM, Schmit B. (1994) Pharmacokinetic optimisation of asthma treatment. Clinical Pharmacokinetics, 26, 396-418.
13. Horn CR, Clark TJH, Cochrane GM. (1990) Compliance with inhaled therapy and morbidity from asthma. Respiratory Medicine, 84, 67-70.
14. Horn CR, Essex E, Hill P, Cochrane GM. (1989) Does urinary salbutamol reflect compliance with the aerosol regimen in patients with asthma? Respiratory Medicine, 83, 15-18.
15. Jacobson GA, Peterson GM. (1994) High performance liquid Chromatographic assay for the simultaneous determination of ipratropium bromide, fenoterol, salbutamol and terbutaline in nebuliser solution. Journal of Pharmaceutical and Biomedical Analysis, 12, 825-832.
16. Jacobson GA, Peterson GM. (1995) Stability of ipratropium bromide and salbutamol nebuliser solution admixtures. International Journal of Pharmacy Practice, 3, 169-173.
17. Morgan DJ, Paull JD, Richmond BH, Wilson-Evered E, Ziccone SP. (1986) Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate. British Journal of Clinical Pharmacology, 22, 587-593.
18. Hildebrandt R, Wagner B, Preiss-Nowzohour K, Gundert-Remy U. (1994) Fenoterol metabolism in man: sulphation versus glucuronidation. Xenobiotica, 24, 71-77.
19. Brashear WT, Kuhnert BR, Wei R. (1988) Maternal and neonatal urinary excretion of sulfate and glucuronide ritodrine conjugates. Clinical Pharmacology and Therapeutics, 43, 634-641.
20. Clarke LC, Thompson HL. (1949) Determination of creatine and creatinine in urine. Analytical Chemistry, 21, 1218-1221.
21. Newman SP. (1985) Aerosol deposition considerations in inhalation therapy. Chest. 88, S152-S160.
22. Bernard A, Lauwerys R. (1987) General principles for biological monitoring of exposure to chemicals. In: Biological monitoring of exposure to chemicals: organic compounds, eds Ho MH, Dillon K, pp. 1-16. John Wiley and Sons, New York.
23. Apostoli P, Brugnone F, Perbelline L, et al. (1982) Biomonitoring of occupational toluene exposure. International Archives of Occupational and Environmental Health. 50, 153-168.
24. Kampmann J, Siersback-Nielsen K, Kristensen M, Hansen JM. (1974) Rapid evaluation of creatinine clearance. Acta Medica Scandinavica, 196, 517-520.
25. Morgan DJ. (1990) Clinical pharmacokinetics of /agonists. Clinical Pharmacokinetics, 18, 270-294.
26. Penna AC, Dawson KP, Manglick P, Tam J. (1993) Systemic absorption of salbutamol following nebuliser delivery in acute asthma. Acta Paediatrica Scandinavica, 82, 963-966.
27. Shenfield GM, Evans ME, Paterson JW. (1974) The effect of different nebulisers with and without intermittent positive pressure breathing on the absorption and metabolism of salbutamol. British Journal of Clinical Pharmacology, 1, 295-300.
28. Chapman KR, Kesten S, Szalai JP. (1994) Regular vs. as-needed inhaled salbutamol in asthma control. Lancet, 343, 1379-1382.
29. Drazen JM, Israel E, Boushey HA, et al. (1996) Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. New England Journal of Medicine, 335, 841-847.